Less than 1 min 10/02/22
Author name: met_ra_ric

Uncovering current trends and drivers in the pharmaceutical oral solid dosage market

One of the most significant impacts on the OSD market during the last decade has been the growth in the oncology sector.

Our vice president Brad Gold recently joined a roundtable discussion in The Manufacturing Chemist on oral solid dosage trends alongside other industry leaders. In it, he observes that the number of clinical-stage cancer programmes has risen steeply and continues to dominate the landscape.

Read part one of the full article to uncover the factors that have impacted the OSD market and the trends we can expect to see in the near future.